Insider Transactions in Q4 2021 at Processa Pharmaceuticals, Inc. (PCSA)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2021
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
6,000
+0.69%
|
$24,000
$4.0 P/Share
|
|
Dec 06
2021
|
Justin W Yorke |
SELL
Open market or private sale
|
Indirect |
4,200
-0.78%
|
$16,800
$4.71 P/Share
|
|
Dec 03
2021
|
Patrick Lin Chief Business - Strategy Off |
BUY
Open market or private purchase
|
Direct |
3,500
+0.81%
|
$14,000
$4.8 P/Share
|
|
Dec 03
2021
|
Justin W Yorke |
SELL
Open market or private sale
|
Indirect |
5,500
-1.01%
|
$22,000
$4.84 P/Share
|
|
Oct 06
2021
|
Robert Michael Floyd Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,663
-33.19%
|
-
|
|
Oct 06
2021
|
Robert Michael Floyd Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+46.3%
|
-
|